In a 2022 analysis of the role of cathepsin L in neuroblastoma chemoresistance, human tissue samples from the R2 Genomics and Visualisation Platform revealed that higher mRNA levels of cathepsin L were associated with significantly poorer survival and advanced tumour stages, though this finding did not reach statistical significance [ 17 ].
← all excerpts
Identifying Molecular Probes for Fluorescence-Guided Surgery in Neuroblastoma: A Systematic Review.
1
—
—